Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Postoperative Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

NCT06476067 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06476067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Postoperative Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2006
Completion date
June 18, 2028
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dna methylation, esophageal cancer, recurrence